| Application no. and date | 15741222.2 (espacenet) (Federated) (European Patent Register), 20150724 | | Patent/reg. no. and date | DK/EP 3193911, 20230906 | | Publication date | 20170726 | | Priority no. and date | EP 14178563, 20140725 | | EP pub. no. and date |
EP 3193911 20170726 | | Effective date | | | Applicant/owner | CSL Behring GmbH, Emil-von-Behring-Strasse 76
35041 Marburg, DE | | Applicant ref. no. | PV1717DKEP | | Inventor | Metzner, Hubert, Im Boden 6
35041 Marburg, DE,
SCHMIDBAUER, Stefan, Am Hofacker 11
35094 Lahntal, DE,
ROBBEL, Lars, Elbinger Strasse 12
35083 Wetter, DE | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/37 (2006.01) , A61P 7/04 (2006.01) | | Title | Forbedrede faktor VII-præparater til brug ved behandling af hæmofili A | | Int. application no. | EP2015067014 | | Int. publication no. | WO2016012595 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
